임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

14건 표시

1/2상모집 중· Carcinoma, Non-Small-Cell Lung
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
리드: 얀센(J&J)
상세 →NCT07227025
1/2상모집 중· Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
협력: 얀센(J&J)
상세 →NCT07002320
1/2상모집 중· Squamous Cell Carcinoma of Head and Neck
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
리드: 얀센(J&J)
상세 →NCT06385080
1/2상모집 중단 (진행 중)· Lung Cancer
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
협력: 얀센(J&J)
상세 →NCT05845671
1/2상모집 중· HIV Infections
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
협력: 얀센(J&J)
상세 →NCT05674656
1/2상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell Lung
A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer
리드: 얀센(J&J)
상세 →NCT05908734
1/2상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell Lung
A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
리드: 얀센(J&J)
상세 →NCT05488314
1/2상모집 중단 (진행 중)· Lymphoma, Non-Hodgkin
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
리드: 얀센(J&J)
상세 →NCT05421663
1/2상모집 중· Advanced or Metastatic Colorectal Cancer
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
리드: 얀센(J&J)
상세 →NCT05379595
1/2상모집 중· Non-Muscle Invasive Bladder Neoplasms
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
리드: 얀센(J&J)
상세 →NCT05316155
1/2상모집 중· Acute Leukemia
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
리드: 얀센(J&J)
상세 →NCT04811560
1/2상모집 중단 (진행 중)· Multiple Myeloma
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
상세 →NCT04586426
1/2상모집 중단 (진행 중)· Urothelial Carcinoma
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
리드: 얀센(J&J)
상세 →NCT03473743
1/2상모집 중단 (진행 중)· Neoplasms
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
리드: 얀센(J&J)
상세 →NCT02908906

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.